Cambridge Biomedical Campus Hills Road, Cambridge, CB2 2QQ

opportunities for patient-centred research, CBC nurtures creative alliance and collaboration and creates a pathway for success.

By co-locating education, research, patient care and commercial R&D on a single site, ideas can be shared and successful results can translate into tangible benefits for patients quickly and efficiently.

Opportunities for bespoke office and laboratory facilities are now available on the Phase 2 expansion of the Campus.

In 2009, planning permission covering 70 acres (28 hectares) gross became the catalyst for the first phase expansion of the Campus, raising its status into a truly internationally competing academic health science centre. The ensuing six years has seen new committed development hit 1,800,000 sq ft (167,224 sq m) gross.

With the Phase 1 expansion land now fully committed, the Phase 2 development is now underway. With a landscape-led approach, this next stage will thread a series of new high specification office and laboratory buildings between a string of green, shared spaces to promote formal and informal meetings. Anchoring the Phase 2 expansion land is the Abcam headquarters, a new 100,000 sq ft (9,290 sq m) net Grade A office and laboratory building, built to suit their business needs.

The total Phase 2 floor area available for development is approx 807,300 sq ft (75,000 sq m) gross, comprising approx 636,400 sq ft (59,122 sq m) of commercial floor space, including Abcam, and approx. 171,000 sq ft (15,878 sq m) gross of clinical floor space.

Cambridge Medipark Limited, a joint venture between Liberty Property Trust and Countryside Properties, is the developer of the Phase 1 and Phase 2 expansion of the CBC.

The developer has already delivered enhanced infrastructure to serve CBC, creating a road link through to the west and helping to deliver Guided Bus Services to the Campus.